Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong
· Delayed Price · Currency is HKD 0.0990
-0.0020 (-1.98%)
At close: Mar 10, 2026
Tianda Pharmaceuticals Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | -67.37 | -61.37 | -24.16 | -54.64 | -19.77 | -27.14 | Upgrade
|
| Depreciation & Amortization | 36.59 | 36.28 | 34.47 | 48.25 | 20.03 | 19.28 | Upgrade
|
| Other Amortization | 1.95 | 1.95 | 1.94 | 2 | 2.12 | 1.33 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.1 | 0.1 | -0.14 | -1.25 | -12.03 | 0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.34 | 1.34 | - | - | 1.58 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.12 | 0.02 | 0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.6 | -0.6 | 0.79 | 0.62 | 0.44 | -0.05 | Upgrade
|
| Other Operating Activities | 57.59 | -2.16 | -4.68 | -7.07 | -20.04 | -8.44 | Upgrade
|
| Change in Accounts Receivable | 26 | 26 | 33.31 | -14.63 | 9.08 | -45.1 | Upgrade
|
| Change in Inventory | 23.5 | 23.5 | -18.9 | 19.23 | -8.68 | -11.39 | Upgrade
|
| Change in Accounts Payable | 4.85 | 4.85 | 35.48 | -32.97 | 13.41 | 55.16 | Upgrade
|
| Change in Other Net Operating Assets | -39.6 | -39.6 | -107.86 | 142.23 | 5.62 | -21.39 | Upgrade
|
| Operating Cash Flow | 44.37 | -9.7 | -49.76 | 101.9 | -8.23 | -37.63 | Upgrade
|
| Capital Expenditures | -21.25 | -20.61 | -49.28 | -33.28 | -53.76 | -145.68 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.09 | 0.09 | 0.28 | 1.63 | 0.03 | 0 | Upgrade
|
| Divestitures | - | - | - | - | 151.9 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -9.97 | -16.88 | -17 | - | - | -0.77 | Upgrade
|
| Investment in Securities | -11.35 | -10.86 | -6.14 | 14.49 | -13.77 | 5.27 | Upgrade
|
| Other Investing Activities | 15.95 | 16.48 | 3.03 | 4.34 | 1.95 | 3.44 | Upgrade
|
| Investing Cash Flow | -26.53 | -31.78 | -69.1 | -12.81 | 86.35 | -137.73 | Upgrade
|
| Long-Term Debt Issued | - | 75.92 | 43.46 | - | 33.46 | 110.61 | Upgrade
|
| Total Debt Issued | 117.99 | 75.92 | 43.46 | 21.54 | 33.46 | 110.61 | Upgrade
|
| Long-Term Debt Repaid | - | -100.98 | -70.03 | - | -25.31 | -10.38 | Upgrade
|
| Total Debt Repaid | -140.93 | -100.98 | -70.03 | -36.68 | -25.31 | -10.38 | Upgrade
|
| Net Debt Issued (Repaid) | -22.94 | -25.06 | -26.58 | -15.14 | 8.15 | 100.22 | Upgrade
|
| Common Dividends Paid | -3.17 | -5.59 | -5.59 | -23.5 | -8.56 | -2.53 | Upgrade
|
| Other Financing Activities | - | - | -25.23 | 0.12 | -0.89 | -6.94 | Upgrade
|
| Financing Cash Flow | -26.11 | -30.65 | -57.39 | -38.52 | -1.3 | 90.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.14 | -4.63 | -1.58 | -42.21 | 8.93 | 20.9 | Upgrade
|
| Net Cash Flow | -6.13 | -76.75 | -177.84 | 8.37 | 85.76 | -63.72 | Upgrade
|
| Free Cash Flow | 23.12 | -30.3 | -99.04 | 68.63 | -61.98 | -183.32 | Upgrade
|
| Free Cash Flow Margin | 7.45% | -9.18% | -18.61% | 12.55% | -12.16% | -38.65% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.01 | -0.05 | 0.03 | -0.03 | -0.09 | Upgrade
|
| Cash Interest Paid | 4.85 | 4.85 | 4.95 | 6.72 | - | 0.57 | Upgrade
|
| Cash Income Tax Paid | 5.96 | 5.96 | -0.37 | 0.41 | - | 3.57 | Upgrade
|
| Levered Free Cash Flow | -16.89 | -71.25 | -112.42 | - | 101.92 | -184.5 | Upgrade
|
| Unlevered Free Cash Flow | -14.24 | -68.22 | -109.33 | - | 102.37 | -184.14 | Upgrade
|
| Change in Working Capital | 14.76 | 14.76 | -57.97 | 113.86 | 19.43 | -22.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.